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Abstract The neurodegenerative disease glaucoma is
characterised by the progressive death of retinal ganglion
cells (RGCs) and structural damage to the optic nerve
(ON). New insights have been gained into the pathogenesis
of glaucoma through the use of rodent models; however, a
coherent picture of the early pathology remains elusive.
Here, we use a validated, experimentally induced rat
glaucoma model to address fundamental issues relating to
the spatio-temporal pattern of RGC injury. The earliest
indication of RGC damage was accumulation of proteins,
transported by orthograde fast axonal transport within
axons in the optic nerve head (ONH), which occurred as
soon as 8 h after induction of glaucoma and was maximal by
24 h. Axonal cytoskeletal abnormalities were first observed
in the ONH at 24 h. In contrast to the ONH, no axonal
cytoskeletal damage was detected in the entire myelinated
ON and tract until 3 days, with progressively greater
damage at later time points. Likewise, down-regulation of
RGC-specific mRNAs, which are sensitive indicators of
RGC viability, occurred subsequent to axonal changes at
the ONH and later than in retinas subjected to NMDA-
induced somatic excitotoxicity. After 1 week, surviving,
but injured, RGCs had initiated a regenerative-like
response, as delineated by Gap43 immunolabelling, in a
response similar to that seen after ON crush. The data
presented here provide robust support for the hypothesis
that the ONH is the pivotal site of RGC injury following
moderate elevation of IOP, with the resulting anterograde
degeneration of axons and retrograde injury and death of
somas.
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Introduction
Glaucoma refers to a family of ocular diseases with mul-
tifactorial aetiology united by a clinically characteristic
optic neuropathy. Pathologically, glaucoma is character-
ised by a loss of all retinal ganglion cell (RGC)
compartments: somata, axons and dendrites; clinically, loss
of axons at the optic nerve head (ONH) heralds the diag-
nosis of glaucoma. This observation, together with other
converging clinical evidence, has given rise to a long-
standing belief that the foremost site of injury is at the
ONH [39]. Yet, the pathogenesis of glaucoma remains
poorly understood. Evidence supporting the ONH as the
primary locus of injury is circumstantial, whilst not much
is known about the molecular pathways involved in the loss
of RGCs and their axons. To date, treatment options for
glaucoma remain limited to lowering intraocular pressure
(IOP), the highest profile risk factor for the disease [23].
To facilitate a greater understanding of glaucoma, a
number of rodent paradigms have been developed. These
can broadly be divided into rat models, in which elevated
IOP is induced experimentally [33], and mouse models,
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where IOP elevation occurs spontaneously [18]. Of
particular importance has been the discovery and charac-
terisation of the DBA/2J inbred mouse strain [19]. DBA/2J
mice exhibit a form of pigmentary glaucoma featuring an
age-related elevation of IOP and progressive optic neu-
ropathy. In recent years, a substantive body of work has
been conducted on DBA/2J mice, providing new insights
into the spatio-temporal pattern of RGC dysfunction and
degeneration. A consistent view on the chronology of
pathological events in this disease model is, however, still
to be reached. For example, Howell et al. [16] provided
robust evidence for an early insult at the lamina of the
ONH with Wallerian-like degeneration of axons distal to
the site of injury. In contrast, Crish et al. [12] ascertained
that axonal transport dysfunction and axon degeneration
appear first at the superior colliculus with a distal-proximal
progression, findings in broad agreement with earlier work
[44]. Furthermore, somatic alterations in RGCs, including
downregulation of mRNA synthesis and abnormal neuro-
filament labelling, have been described as occurring more
or less simultaneously [17], or subsequent to [5], retrograde
axon transport dysfunction.
Certain strengths of the DBA/2J mouse as a relevant
model for human glaucoma, including its gradual pro-
gression, unpredictable timing and inter-individual
variability, make unequivocal identification of the
sequence of events problematic. Here, we use a validated,
experimentally induced rat glaucoma model [26] to address
several fundamental issues. These include ascertaining the
spatio-temporal pattern of orthograde axonal transport
disruption and its correlation with IOP elevation, delin-
eating the site of initial axonal cytoskeletal damage and
determining any association with altered neurofilament
phosphorylation, documenting the timing of RGC somal
injury and whether RGCs attempt to regenerate their
injured axons, and finally, comparing the pattern of injury
observed in glaucoma with those seen after optic nerve
crush or NMDA-induced excitotoxicity, the classical
methods of eliciting axonal and somato-dendritic death of
RGCs, respectively.
Materials and methods
Animals and procedures
This study was approved by the Animal Ethics Committees
of the Institute of Medical and Veterinary Science and the
University of Adelaide and conforms to the Australian
Code of Practice for the Care and Use of Animals for
Scientific Purposes, 2004. All experiments conformed to
the ARVO Statement for the Use of Animals in Ophthal-
mic and Vision Research. Adult Sprague–Dawley rats
(200–250 g) were housed in a temperature- and humidity-
controlled environment with a 12-h light, 12-h dark cycle
and were provided with food and water ad libitum.
For experimental glaucoma experiments, rats were
anaesthetised with 100 mg/kg ketamine and 10 mg/kg
xylazine. Ocular hypertension was then induced in the
right eye of each animal by laser photocoagulation of the
trabecular meshwork using a slightly modified protocol
[14] of the method described by Levkovitch–Verbin et al.
[26]. IOPs were measured in both eyes at baseline, 8 h,
days 1, 3, 7 and 14 using a rebound tonometer factory
calibrated for use in rats. No animals were excluded for
reasons relating to inadequate IOP elevation. Two animals
were excluded as a result of death under anaesthesia and
two due to hyphema. Two cohorts of rats were used in the
current study. The first cohort was used for immunohis-
tochemistry/histology of the retina, ONH, optic nerve
(ON) and optic tract (OT). The number of rats analysed at
each time point was as follows: 8 h (n = 4), 1 day
(n = 8), 3 days (n = 10), 7 day (n = 9), 14 days
(n = 10). In addition, three rats were killed at 2 days and
used for transverse sectioning of the ONH. For axonal
tracing, 4 rats were injected intravitreally with 5 ll of
0.1% AlexaFluor 594-conjugated cholera toxin b-subunit
(CTB) dissolved in sterile PBS. After 24 h, right eyes
were lasered as above. Rats were killed at 2 days and
taken for immunohistochemistry. The second cohort was
used for RT-PCR/Western blotting of the retina and ON.
The number of rats analysed at each time point was as
follows: 1 day (n = 4), 3 days (n = 7), 7 days (n = 7),
14 days (n = 4). The chiasm from each rat was taken for
immunohistochemistry to verify that the procedure had
induced an injury response commensurate with the first
cohort.
For excitotoxicity experiments, an intravitreal injection
of 30 nmol of NMDA (5 ll in sterile saline) was per-
formed in one eye. The control eye was injected with
vehicle. The number of rats analysed at each time point
for RT-PCR of the retina was as follows: 6 h (n = 7),
1 day (n = 6), 3 days (n = 6), 7 days (n = 7). In addi-
tion, four rats were taken at each time point for
immunohistochemistry. For ON crush experiments, the
superior muscle complex was divided and the ON
exposed by blunt dissection. The ON was then crushed
3-mm posterior to the globe under direct visualisation
using number 5 forceps for 20 s. ON crush produces
complete disruption of the RGC axons, which can be seen
as a separation of the proximal and distal optic nerve ends
within the meningeal sheath. To avoid confusing retinal
ischaemic changes with the effects of crush, the fundus
was observed ophthalmologically immediately after nerve
crush. A total of six rats were subjected to ON crush, all
of which were killed at 14 days.
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Tissue processing and histology
All rats were killed by trans-cardial perfusion with physi-
ological saline under deep anaesthesia and, in those rats
where tissue was not taken for RT-PCR/Western blotting,
subsequently with 4% paraformaldehyde. Initially, the
brain was removed. Next, each eye with ON, optic chiasm
and the proximal part of the OT attached was carefully
dissected. From the dissected tissue, a short piece of ON
(2-mm long), 1.5-mm behind the globe, was removed for
resin embedding. The brain, globe, remaining ON, chiasm
and proximal segment of OT were fixed in 10% buffered
formalin for at least 24 h. Following fixation, the brain was
positioned in the Kopf rat brain blocker (Kopf Instruments
PA001) and 2-mm coronal slices were taken in a dorsal-
caudal direction. Brain slices, along with the globe and
optic pathway, were processed for routine paraffin-
embedded sections. Globes were embedded sagitally; ONs
and chiasmata were embedded longitudinally. In all cases,
4-lm serial sections were cut. As detailed above, three rats
killed at 2 days were used for transverse sectioning of the
ONH. The short piece of proximal ON taken for resin
sectioning and toluidine blue staining was treated as pre-
viously reported [14].
Immunohistochemistry
Colorimetric immunohistochemistry was performed as
previously described [9]. In brief, tissue sections were
deparaffinized before treatment with 0.5% H2O2 for 30 min
to block endogenous peroxidase activity. Antigen retrieval
was achieved by microwaving the sections in 10-mM citrate
buffer (pH 6.0). Tissue sections were then blocked in PBS
containing 3% normal horse serum, incubated overnight in
primary antibody, followed by consecutive incubations with
biotinylated secondary antibody and streptavidin-peroxi-
dase conjugate. Colour development was achieved with
30-,30-diaminobenzidine. Sections were counterstained with
haematoxylin, dehydrated and mounted. Specificity of
antibody staining was confirmed by incubating adjacent
sections with isotype controls (mouse IgG1 and IgG2a
isotype controls) for monoclonal antibodies, or normal
rabbit/goat serum for polyclonal antibodies.
Double labelling fluorescent immunohistochemistry was
performed as previously described [9]. In brief, visualisa-
tion of one antigen was achieved using a three-step
procedure (primary antibody, biotinylated secondary anti-
body, streptavidin-conjugated AlexaFluor 594), whilst
the second antigen was labelled by a two-step procedure
(primary antibody, secondary antibody conjugated to
AlexaFluor 488). In summary, sections were prepared as
above, except for the omission of the endogenous peroxi-
dase block, then incubated overnight at room temperature
in the appropriate combination of primary antibodies. On
the following day, sections were incubated with the
appropriate biotinylated secondary antibody (1:250) for the
three-step procedure plus the correct secondary antibody
conjugated to AlexaFluor 488 (1:250, Invitrogen) for the
two-step procedure for 30 min, followed by streptavidin-
conjugated AlexaFluor 594 (1:500) for 1 h. Sections were
then mounted using anti-fade mounting medium and
examined under a confocal fluorescence microscope. Pri-
mary antibody details are provided in Supplementary
Table 1.
Evaluation of histology and immunohistochemistry
All assessments of ON injury were performed in a ran-
domized, blinded manner. Loss of RGC axons in the ONs
of glaucomatous eyes was assessed using a semi-quanti-
tative ON grading scheme based on the toluidine blue-
stained cross-sections [8, 14], where grade 0 corresponds to
no damage, grade 5–50% axon loss, and grade 10–100%
axonal loss. Of note, if the calculated damage grade was
zero, but the nerve contained at least 20 damaged axons
within the whole cross-section, the grade was recorded as 1
as a nominal indication that the nerve was damaged.
b-Amyloid precursor protein (APP) accumulation in the
ONH as a result of disrupted axonal transport was assessed
semi-quantitatively using a 4-point grading system, ranging
from 0 = undetectable to 3 = numerous intensely stained
APP-positive axons covering a substantial area of the pre-
laminar to post-laminar ONH. The APP score of each rat
was then correlated with the peak IOP elevation of that rat
and with the IOP at the time of death. Statistical analysis of
correlations were performed by GraphPad Prism 5.0b
(GraphPad Software Inc., La Jolla, CA) using non-para-
metric tests.
Quantification of SMI-32 immunolabelling in longitu-
dinal sections of the medial ON and proximal OT was
performed as previously described [14]. In brief, immu-
nostained sections, each expressing a representative level
of immunoreactivity, were photographed at 2009. They
were then imported into NIH Image-J 1.42q software
(http://www.rsb.info.nih.gov/ij/), where they underwent
colour deconvolution to separate diaminobenzidine reac-
tion product from haematoxylin counterstain [41]. Images
were subsequently analysed with regard to the specifically
stained area in pixels using the in-built functions of the
Image-J software. Statistical analysis was carried out by
ANOVA followed by post hoc Tukey’s test.
Electrophoresis/Western blotting
The entire ON was taken for Western blotting except for
1.5 mm at the proximal and distal ends; thus, only the
Acta Neuropathol (2011) 121:737–751 739
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myelinated segment of the nerve was analysed. Retinas and
ONs from 3 to 7 days, and ONs from 14-day experimental
glaucoma rats were processed for Western blotting as
previously described [9]. In brief, after electrophoresis,
samples were transferred onto PVDF membranes. Fol-
lowing a block of non-specific binding, blots were probed
with primary antibodies (see Supplementary Table 1),
appropriate secondary antibodies conjugated to biotin, and
streptavidin-peroxidase conjugate. Blots were then devel-
oped and the images captured and analysed for
densitometry. Densitometry values were normalised for
actin. Statistical analysis was performed by Kruskall–
Wallis followed by Mann–Whitney for comparison of
SMI-32, SMI-37 and SMI-31 expression in 3, 7 and
14 days ON samples and by Student’s paired t test for
Gap43 expression in treated versus control retinas.
Real-time RT-PCR
Reverse-transcription polymerisation chain reaction (RT-
PCR) studies were carried out as described previously [11].
In brief, retinas were dissected, total RNA was isolated and
first-strand cDNA was synthesised from 2-lg DNase-trea-
ted RNA. Real-time PCR reactions were carried out in
96-well optical reaction plates using the cDNA equivalent
of 20-ng total RNA for each sample in a total volume of
25 ll containing 19 SYBR Green PCR master mix (Bio-
Rad), forward and reverse primers at a final concentration
of 400 nM. The thermal cycling conditions were 95C for
3 min and 40 cycles of amplification comprising 95C for
12 s, 63C for 30 s and 72C for 30 s. Primer sets used
were as follows (sense primer, antisense primer, product
size, accession number): GAPDH (50-TGCACCACCAAC
TGCTTAGC-30, 50-GGCATGGACTGTGGTCATGAG-30,
87 bp, NM_017008), NFL (50-ATGGCATTGGACATT
GAGATT-30, 50-CTGAGAGTAGCCGCTGGTTAT-30,
105 bp, AF031880), Thy1.1 (50-CAAGCTCCAATAAAA
CTATCAATGTG-30, 50-GGAAGTGTTTTGAACCAGC
AG-30, 83 bp, X03150). After the final cycle of the PCR,
primer specificity was checked by the dissociation (melt-
ing) curve method. In addition, specific amplification was
confirmed by electrophoresis of PCR products on 3%
agarose gels. PCR assays were performed using the IQ5
icycler (Bio-Rad) and all samples were run in duplicate.
The results obtained from the real-time PCR experiments
were quantified using the comparative threshold cycle (CT)
method (DDCT) for relative quantitation of gene expression
[27], corrected for amplification efficiency [36]. All values
were normalised using the endogenous housekeeping gene
GAPDH and expressed relative to controls. Statistical
analysis was carried out by ANOVA followed by post hoc
Tukey’s test. The null hypothesis tested was that CT dif-
ferences between target and housekeeping genes would be
the same in control and experimental retinas.
Results
Axonal transport disruption at the ONH is an early
event during experimental glaucoma
The ONH has long been considered a site of early axonal
transport failure in glaucoma [1, 29, 37, 39, 40], but recent
data from rodents indicate that distal axons are affected
first [12]. To address this important issue, we performed
immunolabelling for APP, a protein synthesised by RGCs
[30] and conveyed along the ON by fast axonal transport.
We found accumulation of APP in axons in the pre- and
post-laminar ONH as early as 8 h following induction of
raised IOP (Fig. 1a, b). By 24 h, intense APP immunore-
activity was observed throughout the ONH, a result that
was typical of the majority of rats analysed within the first
7 d. By 14 d, however, not much APP accumulation was
detectable at the ONH in most animals (Fig. 1c–f). To
ascertain whether axonal transport disruption correlated
with the peak increase in IOP or the terminal IOP, repre-
sentative sections from the central ONH of every rat were
graded for APP accumulation and related to the peak IOP
value recorded from that rat and to the IOP at the time of
death. A Spearman’s rank correlation was then performed.
The maximal APP score was documented at 24 h after
induction of experimental glaucoma, with similar, some-
what lower values obtained at 3 and 7 days, and a
substantially lower grade at 14 days (Table 1). There was
no correlation between peak IOP and APP grade (r = 0.27,
P = 0.11). In contrast, the terminal IOP showed a
Table 1 Grading of APP accumulation at the ONH at various times after induction of experimental glaucoma
Time Cont eyes 8 h (n = 4) 1 day (n = 7) 3 days (n = 8) 7 days (n = 9) 14 days (n = 10)
Integral exposure IOPa – – 16.5 ± 2.1 47.1 ± 11.1 97.7 ± 8.7 189.2 ± 13.2
Peak increase in IOPa – 28.5 ± 2.7 24.2 ± 4.6 25.8 ± 5.4 26.3 ± 2.5 24.2 ± 2.2
IOP increase at time of deatha – 28.0 ± 3.0 21.5 ± 4.0 15.0 ± 7.0 13.3 ± 2.6 5.0 ± 1.3
APP grade 0.0 ± 0.0 1.5 ± 0.3 3.8 ± 0.2 2.9 ± 0.3 2.7 ± 0.2 1.5 ± 0.2
a Calculated as IOP of treated eye—IOP of untreated contralateral eye and expressed in mmHg
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significant correlation with the APP grade (r = 0.47,
P = 0.004). The results indicate, as expected, that elevated
IOP at the time of death is a risk factor for axonal transport
disruption. It is, however, noteworthy that the correlation
between APP grade and terminal IOP (r = 0.47) was not
high, indicating that considerable variation exists between
rats with regard to how raised IOP affects axonal viability.
We next sought to identify the spatial distribution of
axonal transport failure. To ascertain whether axonal
transport disruption is restricted to the ONH, we performed
double labelling immunohistochemistry of APP with
myelin basic protein (MBP) in both longitudinal (Fig. 2a–
c) and transverse sections of the ONH and proximal ON
(Fig. 2d–i). The results clearly showed that APP immu-
noreactivity was not associated with the myelinated portion
of the ON. In addition, it was apparent that APP accumu-
lation in the lamina was not uniform, but regionalised and
asymmetric (Fig. 2h), a result that corresponds with pre-
vious findings of regionalised RGC and axonal loss in the
DBA/2J mouse [16, 44]. To identify whether any distal
parts of the optic pathway feature axonal transport dis-
ruption, medial and distal sections of the ON and OT were
immunostained for APP. Images of the ONH, medial ON
and proximal OT from a typical 3-day rat are shown
(Fig. 2j–l). No sites of APP accumulation were detected
beyond the ONH at any time point, indicating the crucial
significance of this structure in the pathology of experi-
mental glaucoma.
To further characterise the nature of axonal transport
disruption during experimental glaucoma, we performed
immunostaining for two additional molecules, synaptophysin
and brain-derived neurotrophic factor (BDNF), that are
synthesised by RGCs and undergo anterograde, fast axonal
transport [6, 31]. Synaptophysin displayed broadly similar
patterns of accumulation at the ONH as APP, although
differences were evident. APP was observed in highest
amounts in the pre-laminar ONH and in axons at the
margins of the ONH; synaptophysin extended further into
the ONH and was distributed more evenly (Fig. 3b–i).
BDNF also accumulated at the ONH, but was in lower
abundance than APP and was largely pre-laminar.
BDNF and synaptophysin both colocalized with APP
(Fig. 3d–f, j). The results suggest that all molecules
undergoing anterograde fast axonal transport are disrupted
by chronic IOP elevation. To confirm that accumulations of
APP and synaptophysin represent disrupted fast axonal
transport, we performed double labelling in ocular hyper-
tensive rats that had been labelled with the neural tracer
cholera toxin b-subunit (CTB). After 2 days of experi-
mental glaucoma, CTB was associated with RGC somata,
dendrites and axons, and accumulated at the ONH in many
of the same axons as APP and synaptophysin (Fig. 3g–i).
Double labelling of APP with microglial and astocytic
markers (Fig. 3k, l) failed to show any colocalisation
indicating APP immunoreactivity resided solely within
axons.
Characterisation of axonal cytoskeleton damage
during experimental glaucoma
Our next goal was to define the temporal relationship
between disrupted axonal transport and damage to the ON
Fig. 1 Accumulation of APP at the ONH at various times following
induction of experimental glaucoma. In normal rats, APP immuno-
reactivity is localised to RGC bodies, but only very low intensity
labelling is associated with RGC axons in the ONH and ON (a). By
8 h after induction of chronic ocular hypertension, accumulation of
APP is evident within some axons in the pre- and post-laminar ONH
(b arrows). At 24 h, intense APP immunoreactivity is typically
observed throughout the ONH (c). Analysis of rats at 3 d (d) and 7 d
(e) shows APP immunolabelling in the ONH remains high, although
not as widespread as 1 day. By 14 days after induction of experi-
mental glaucoma (f), not much APP immunoreactivity is observed in
the pre- or post-laminar ONH. Scale bar 100 lm
Acta Neuropathol (2011) 121:737–751 741
123
axonal cytoskeleton. This provides information on whether
axonal transport deficiencies are functional or mechanical.
The standard methodology for evaluating ON injury is
quantitative evaluation of transverse sections of the prox-
imal nerve stained with toluidine blue [33]. Accordingly,
we analysed ONs for damage at increasing times after
induction of raised IOP (Fig. 4). At 1 day, when axonal
transport disruption is maximal, there was no evidence of
any axonal abnormalities. Between 3 and 14 days, axonal
disruption increased dramatically, which was manifest
initially as the enlargement of a few axons, then progressed
to the appearance of hyperdense axons, myelin disruption
and reduced axon density.
The toluidine blue methodology is well suited to iden-
tifying gross abnormalities and axonal loss; however, it
may lack the sensitivity to detect early or subtle axonal
injury. An alternative, complementary technique involves
analysis of longitudinal sections immunostained for spe-
cific markers of the axonal cytoskeleton. This approach is
routinely employed for delineation of axonal damage in
other white matter tracts. Initially, we evaluated the sen-
sitivity and efficacy of eight immunohistochemical markers
for detection of early ON damage. SMI-32, an antibody
that recognises the heavy chain of non-phosphorylated
neurofilament (npNFH), was unequivocally the most sen-
sitive indicator. This was the case both at 3 and 7 days, in
rats with slight damage and in rats with numerous abnor-
malities. The pattern of SMI-32 immunolabelling changed
from one consisting of light, uniform staining of axons to
one featuring axonal beading, swellings and spheroids.
Representative images of the eight markers in sections
from the medial ON of a 3-day rat with only a small
number of injured fibres are shown (Supplementary
Fig. 1a).
Next, we utilised SMI-32 to quantify axonal damage.
Sections from the medial ON and proximal OT of 1, 3 and
7 days rats were immunolabelled for SMI-32 (see Sup-
plementary Fig. 1b for typical staining patterns), and the
extent of abnormalities calculated. The results, revealed no
evidence of axonal injury in either location at 1 day, but
significant damage by 3 days, and fourfold greater damage
by 7 days (Table 2). Comparison of the ON with the OT
showed the mean damage level in the OT was somewhat
higher than the ON at the 3-day time point, but there was
Fig. 2 APP accumulation is
restricted to the ONH during
experimental glaucoma. a–
i Feature double labelling
immunohistochemistry of APP
(red) with MBP (green)
showing that axonal transport
disruption occurs only within
the initial, non-myelinated
portion of the nerve; a–
c highlight the ONH and
proximal ON of a rat killed
7 days after induction of
experimental glaucoma in
longitudinal orientation; d–
i show three levels of the
proximal ON of a typical 2 day
rat in cross-sectional plane,
where transverse sections were
taken through the ON at 400 lm
intervals in a distal to proximal
direction showing the mature
myelinated ON (d, e), the early
portion of the myelinated ON (f,
g) and the unmyelinated lower
neck region (h, i), which
features widespread APP
immunolabelling. A rat killed
after 3 days of ocular
hypertension: APP accretion is
clearly visible at the ONH (j),
but not more distally in the ON
(k) or OT (l). Scale bar a and d–
f 100 lm, b, c and g–l 50 lm
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no difference at 7 days. A number of conclusions can be
drawn: first, SMI-32 and toluidine blue provided comple-
mentary results; secondly, despite axonal transport
disruption at the ONH commencing by 8 h, no axonal
cytoskeletal abnormalities were evident in the myelinated
nerve at 24 h; thirdly, degeneration may have commenced,
or proceeded more rapidly, in the distal part of the axon.
The SMI-32 analyses described above relate to the
central portion of the visual pathway. To better understand
whether the primary locus of axonal degeneration is at the
distal or the proximal end of pathway, it is necessary to
analyse the entire tract, from the ONH to the lateral
geniculate nucleus and superior colliculus. Accordingly,
we performed a spatial assessment of SMI-32 immuno-
staining in rats subjected to experimental glaucoma. The
results were as follows: (1) no alterations to SMI-32
immunostaining were noted in the visual pathway at 8 h;
(2) at 1 d, SMI-32 abnormalities, visualised as beading and
swellings, were evident in the pre-laminar and laminar
ONH in some, but not all animals, however, no such
abnormalities were manifest distal to this location in the
entire myelinated ON and OT; (3) after 3 days, SMI-32
abnormalities were apparent throughout the length of the
white matter tract from the ONH via the optic chiasm to the
brachium of the superior colliculus. Figure 5 shows rep-
resentative images from the ONH, optic chiasm and distal
Fig. 3 Comparison of APP with other markers of axonal transport
disruption after induction of experimental glaucoma. In normal rats,
synaptophysin immunoreactivity is localised to post-synaptic termi-
nals in the retina, but only very low intensity labelling is associated
with RGC axons in the ONH and ON (a). At 24 h after induction of
experimental glaucoma, accumulation of synaptophysin (b) is
observed throughout the ONH in a similar pattern to APP (c).
Synaptophysin colocalises with APP, as seen in this rat killed at
7 days (d–f). At 2 days after induction of experimental glaucoma,
CTB (g–i red) is associated with RGC somata, dendrites and axons in
the retina and accumulates throughout the ONH. CTB colocalises
with APP (g green) and with synaptophysin (h, i green). In every rat,
synaptophysin immunoreactivity extends further into the ONH than
APP (b, c, f, h arrows). BDNF (j green) also colocalises with APP
(j red), predominantly in the pre-laminar ONH (arrow). In contrast,
the astrocytic marker GFAP (k green) and the microglial marker iba1
(l green) do not colocalise with APP (k, l red). CTB cholera toxin
b-subunit. Scale bar a–c, j, k 100 lm, d–f 50 lm, g–i l, 25 lm
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OT. To confirm axonal cytoskeletal abnormalities at the
ONH at 1 day, sections were also immunostained for
neurofilament medium. The pattern of abnormalities pro-
duced was almost identical to SMI-32 (data not shown).
The overall results indicate that axonal cytoskeleton
changes occur first at the ONH.
There is debate as to whether increased or decreased
neurofilament phosphorylation signifies injury in neurode-
generative diseases in general [35] and glaucoma in
particular [22, 42, 45]. As described above, we observed
numerous npNFH (SMI-32) abnormalities in ON sections;
however, it is unclear whether this represents an overall
dephosphorylation of NFH or merely breakdown of the
more labile non-phosphorylated subunit. Thus, we under-
took Western blotting in ON samples from control and
treated eyes using two antibodies, SMI-32 and SMI-37,
which exclusively recognise npNFH (Fig. 6). Each anti-
body detected a protein of 200 kDa signifying native
npNFH, but in treated ONs, a continuum of lower molec-
ular weight proteins reactive to SMI-32 and SMI-37 was
also observed. Densitometry showed no significant (SMI-
32, P = 0.42; SMI-37, P = 0.24) difference in the inten-
sity of the 200 kDa species between the 3, 7 and 14-day
time points. In contrast, there was a marked increase in
intensity of the lower molecular weight products over the
time period analysed (SMI-32, P = 0.036; SMI-37,
P = 0.011). The data indicate that there is no increase in
npNFH in the ON during ocular hypertension-induced
axonal degeneration, rather there is a progressive degra-
dation of npNFH. Western blots performed using the
antibody SMI-31, which exclusively recognises pNFH,
failed to reveal a continuum of lower molecular weight
protein bands.
The ONH is the site of putative axonal regeneration
failure during experimental glaucoma
In the ON, axonal injury is not followed by any beneficial
regeneration. Severed or crushed RGC axons display only
Fig. 4 Transverse sections of ONs stained with toluidine blue at
various times subsequent to induction of experimental glaucoma. At
1 day after induction of chronic ocular hypertension (b), the axonal
structure is unchanged relative to control ONs (a). By 3 days, a few
enlarged axons (black arrowheads) are typically visible (c). After
7 days of experimental glaucoma, reduced axon density and myelin
disruption (black arrows) are evident (d), features that are even more
prevalent after 14 days of raised pressure (e). Mean axonal injury at
increasing times after induction of experimental glaucoma is shown
(f). Scale bar 25 lm
Table 2 Quantification of SMI-32 abnormalities at various times
after induction of experimental glaucoma
Time Control 1 day 3 days 7 days
Medial ON 0.39 ± 0.28 0.13 ± 0.13 24.7 ± 7.2 106.7 ± 31.0
Proximal
OT
0.40 ± 0.17 0.38 ± 0.30 37.0 ± 9.1* 110.5 ± 26.7
Immunoreactivities were quantified (see ‘‘Materials and methods’’)
and expressed as area in pixels (9103)
All values are presented as mean ± SEM, where n = 9 (control),
n = 8 (1 day), n = 10 (3 days), n = 9 (7 days)
Statistical analysis of immunoreactivities was performed by ANOVA
followed by a post-hoc Tukey’s test for multiple comparisons
Significant differences versus controls are indicated by * P \ 0.05
and  P \ 0.001
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transient, local sprouting proximal to the site of damage
[3]. Unlike ON crush or transection, RGCs are lost grad-
ually during experimental glaucoma; moreover, the locus
of injury to RGCs is unclear. Thus, evaluation of the spatio-
temporal pattern of any endogenous axonal regeneration that
occurs during glaucoma will be greatly informative to our
understanding of the pathology of the disease. To achieve
this objective, we analysed expression of growth-associated
protein 43 (Gap43), the classical marker of axonal regen-
eration in the ON [4, 13, 25].
In normal adult rats, negligible Gap43 immunoreactivity
was associated with RGC bodies or their axons (Fig. 7a).
The situation was unchanged at 24 h after induction of
raised IOP, even in rats with widespread axonal transport
disruption and neurofilament damage (Fig. 7b). By 3 days,
limited Gap43 immunohistochemistry was detectable in
RGC axons of some rats, particularly at the level of the pre-
laminar ONH (Fig. 7c), whilst Western blotting showed
that all rats analysed had a markedly upregulated level of
retinal Gap43 protein (Fig. 8a, b). The expression of Gap43
increased further at 7 and 14 days, as evidenced by
immunohistochemistry (Fig. 7d–i) and Western blotting
(Fig. 8a, b). The pattern of Gap43 immunoreactivity in
ocular hypertensive rats was broadly equivalent to that of
APP with accumulation throughout the ONH, but was
significantly delayed in onset. Although APP immuno-
staining was maximal at 1 day and then gradually declined,
the opposite occurred for Gap43. Unlike APP, a few
Gap43-positive axons extended beyond the ONH into the
initial myelinated portion of the ON (Fig. 6f). Neverthe-
less, Western blotting (Fig. 8b) showed no measureable
increase in the Gap43 content of the myelinated ON at
7 days. The overall results suggest that injured RGCs
attempt to regenerate their axons during experimental
glaucoma, but the process fails at the ONH. A caveat to this
conclusion is that Gap43 expression alone is not conclusive
of axonal regeneration. To verify that injured RGCs, rather
than healthy cells, are responsible for re-instigating Gap43
expression, we performed double labelling of Gap43 with
heat shock protein 27 (Hsp27) in retinas subjected to
14 days of experimental glaucoma. Hsp27, a molecular
chaperone induced by cellular stress, is not constitutively
Fig. 5 Axonal degenerative changes in the visual pathway at early
time points during experimental glaucoma. a Representative images
of APP and SMI-32 staining in three regions of the ONH at 1 day
after induction of chronic ocular hypertension. At 1 day, widespread
APP accumulation is evident in axons throughout the ONH. SMI-32-
labelled axon fibres show swellings and beading (arrows) and
vacuolization (arrowhead) in areas of axonal transport disruption.
b Representative images of SMI-32 staining at the level of the optic
chiasm and optic tract 1 and 3 days after induction of chronic ocular
hypertension. Unlike the ONH, the myelinated ON and optic tract
appear normal at 1 day. By 3 days, SMI-32 abnormalities are evident
throughout the length of the white matter tract (black arrows). The
boundaries of the optic tract are demarcated by white arrows. Scale
bar a ONH overview, 45 lm, magnified images, 16.7 lm, b 25 lm
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expressed by RGCs; however, within an ongoing patho-
logical setting, such as axotomy or glaucoma, is
persistently upregulated in severely injured RGCs [21, 24].
The results showed that many RGCs were immunopositive
for both Hsp27 and Gap43 (Fig. 8c) indicating their
increased stress status.
The pattern of injury during experimental glaucoma
displays pathological similarities to optic nerve crush, but
not to NMDA-induced excitotoxicity.
Hitherto, it is unclear whether degeneration of RGC
axons precedes degeneration of RGC somata during glau-
coma. Whilst a body of evidence supports this hypothesis,
other data endorse the view that atrophy of RGC perikarya
occurs first [45]. To elucidate the timing of RGC somatic
injury, we performed a temporal analysis of RGC gene
expression during experimental glaucoma. The rationale
for this approach is that down-regulations of RGC-specific
mRNAs, including Thy1 and neurofilament light (NFL),
are sensitive early indicators of RGC viability [10, 43].
Following induction of raised IOP, negligible down-regu-
lation of Thy1 and NFL had occurred by 24 h (Fig. 9a). By
3 days, the levels of both mRNAs had decreased, but the
changes failed to reach statistical significance. After
7 days, highly significant (P \ 0.001) decreases of Thy1
and NFL were measured. The time courses of these chan-
ges are delayed compared with the axonal responses
described above, indicating that altered gene transcription
occurs subsequent to axonal disruption.
To impart perspective on the results, we assessed RGC
gene expression, disruption of axonal transport and damage
to the axonal cytoskeleton in rats that underwent NMDA-
induced excitotoxicity. NMDA treatment is the classical
method of eliciting somato-dendritic death of RGCs, since
NMDA receptors are present on the soma but not the axon
of the RGC. Moreover, excitotoxicity is implicated in the
pathogenesis of glaucoma [7]. The results were in complete
contrast to those of the glaucoma model. Down-regulation
of Thy1 and NFL mRNAs was in evidence as early as 6 h
after NMDA administration and by 24 h both mRNAs were
maximally down-regulated, signalling death of the RGC
soma (Fig. 9b). Despite the fatal injury to the RGC body,
no disruption to the axonal cytoskeleton, either at the ONH
or within the ON, was detectable at 24 h after NMDA
administration (Fig. 9c). By 2 days, however, axonal
Fig. 6 Expression of npNFH and pNFH in the ON following
induction of experimental glaucoma, as evaluated by Western blotting
using two antibodies, SMI-32 and SMI-37, that recognise npNFH and
one antibody, SMI-31, that recognises pNFH. a Representative blots
from control and treated ONs from four animals killed at 3, 7 and
14 days are shown. Both antibodies recognise a 200 kDa band that
represents native npNFH. A continuum of lower molecular weight
bands reactive to SMI-32 and SMI-37, but not SMI-31, are visible in
the treated ONs, as indicated by the vertical arrows. b Densitometry
measurements (normalised for actin and expressed relative to the
control ON) are provided in the graphs below, where n = 7 (3 days),
n = 7 (7 days) and n = 4 (14 days). *P \ 0.05, **P \ 0.01 com-
pared with controls by Mann–Whitney U test
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swelling and beading was visible throughout the entire ON
and OT (Fig. 9d). Unlike experimental glaucoma, no
accumulation of APP occurred at the ONH following
NMDA treatment (Fig. 9e). The overall results show the
two paradigms of RGC death have quite distinct
pathologies.
Further evidence illustrating the different injury profiles
of experimental glaucoma and excitotoxicity was provided
by comparison of their Hsp27 and Gap43 responses (Sup-
plementary Fig. 2a, b), which, as discussed above, can be
viewed as indicative of ongoing somatic and axonal injury,
respectively. After 14 days of chronic ocular hypertension,
a proportion of surviving (b3-tubulin-labelled) RGCs
expressed Hsp27 and synthesized Gap43. In contrast,
7 days after NMDA administration, surviving RGCs were
Hsp27- and Gap43-negative. Thus, excitotoxicity causes
acute, fatal injury to a proportion of RGCs, but surviving
RGCs are somatically and axonally healthy, whilst glau-
coma damages the axon, but spares the soma of a
proportion of RGCs, leading to ongoing perikaryal stress
and delayed death. To ascertain whether the response seen
during glaucoma is characteristic of ON crush, we also
analysed rats subjected to intraorbital ON crush 14 days
previously. Similar to glaucoma, RGCs from ON crush rats
expressed Hsp27 and synthesized Gap43 (Supplementary
Fig. 2a, b). When compared with glaucoma, substantially
more Gap43 immunoreactivity was observed, which
extended well beyond the ONH. This is to be expected;
however, as the entire population of RGCs is affected by
crush and the site of crush was 3 mm distal to the ONH.
Discussion
In the current study, we have employed a rat model of optic
neuropathy induced by chronic elevation of the IOP together
with a combination of histology, immunohistochemistry,
Western blotting and real-time RT-PCR to address the
spatial and temporal nature of RGC pathology. As identified
by Morrison et al. [33], the advantage of such a model
compared with spontaneous models of chronic ocular
hypertension is that the timing of the IOP increase following
Fig. 7 Gap43 expression in RGC axons following induction of
experimental glaucoma. In control rats (a), minimal Gap43 immuno-
reactivity is associated with RGC bodies or their axons, but a lamina
of punctae is visible in the inner plexiform layer at the border with the
INL (arrowhead). No discernible alteration to the pattern of Gap43
staining is evident at 1 day (b) after induction of chronic ocular
hypertension. By 3 days (c), occasional Gap43-immunopositive fibres
are apparent in the pre-laminar ONH of some rats (arrow). After
7 days (d), numerous axons in the pre- (arrow) and post-laminar ONH
label for Gap43. Three representative rats are shown after 14 days of
experimental glaucoma: the first rat (e) displays intense Gap43
immunoreactivity in the nerve fibre layer and within the ONH; the
second rat (f) displays abundant Gap43-positive axons throughout the
ONH with a few axons extending into the initial myelinated portion of
the ON (Gap43, green, mbp red). The third rat (g–i) has substantial
axonal loss in the ONH (highlighted by asterisk) and features robust
Gap43 labelling of surviving axons in this region of the ON. Scale bar
a–e 100 lm, f–i 50 lm
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the surgical intervention is known. This engenders greater
confidence in conclusions drawn about the chronology of
pathological events. The data presented here provide robust
support for the hypothesis that the ONH is the pivotal, and
likely the primary, site of RGC injury following moderate
elevation of IOP, with resulting anterograde degeneration of
axons and retrograde injury and death of somas.
Anterograde fast axonal transport conveys newly syn-
thesized molecules away from the cell body. Obstruction of
this process rapidly compromises the integrity of the distal
axon. In glaucoma, the lamina cribrosa of the ONH has
long been considered a likely site of axonal transport
failure. This hypothesis was formed after pioneering work
performed in monkeys, which demonstrated that radioac-
tive leucine accumulated within axons at the ONH after
moderate elevation of IOP [1, 29, 37, 38, 40]. Similar
results have been found in pigs [2]. However, current
glaucoma research is mainly performed in rodents, and
rodents lack a true lamina cribrosa. Rats possess a rudi-
mentary structure, whilst mice have no connective tissue
[15, 32]. As such, it is important to ascertain whether the
ONH is an important site of axonal transport failure in
rodents. We achieved this aim by immunolabelling for
proteins (APP, synpatophysin and BDNF) that are routinely
synthesised by RGCs and conveyed along the ON by fast
axonal transport [6, 31]. Because the molecules analysed
are of different molecular weights and have distinct phys-
iological roles, this approach provides biologically
meaningful information about transport viability during
chronic ocular hypertension. Our results showed accumu-
lation of all three proteins within axons at the ONH, but not
distal to this location in the myelinated ON or OT, results
confirmed by the use of the neural tracer CTB. The time
course correlated well with the early monkey studies, with
detectable accumulation by 8 h and widespread dysfunc-
tion from 24 h. By 14 days, however, the mean IOP had
decreased markedly and disruption was measurably lower.
The reduced accumulation of APP at this time point can be
accounted for in two ways: (1) in axons that were not
irreversibly damaged, the lower IOP allows normal trans-
port of APP to resume; (2) axons that were irreversibly
damaged by high IOP have now degenerated. Quigley and
Fig. 8 Gap43 expression in the retina and ON following induction of
experimental glaucoma. a Expression of Gap43 in the retina as
evaluated by Western blotting. Representative blots from control and
treated retinas from four animals killed at 3 and 7 days after induction
of chronic ocular hypertension are shown. b Densitometry measure-
ments (normalised for actin and expressed relative to the control eye)
for retinas and ONs are shown in the accompanying graph, where
n = 7. **P\0.01 by paired Student’s t test (control vs. treated).
c Double labelling immunofluorescence of Gap43 with Hsp27 in a
representative rat killed 14 days after induction of experimental
glaucoma. Gap43-positive RGCs frequently express Hsp27. GCL
ganglion cell layer, INL inner nuclear layer, ONL outer nuclear layer.
Scale bar 25 lm
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Addicks [38] noted that a return to normal IOP within
1 week restored transport in some axons in monkeys.
Previous studies in rats have found results compatible
with the hypothesis that chronically elevated IOP disrupts
active retrograde axonal transport to the retina at the level
of the ONH [28, 42], findings consistent with this study. In
contrast, Crish et al. [12] showed that axonal transport
dysfunction in both spontaneous and induced rodent
models of IOP elevation appeared first at the superior
colliculus and progressed distal proximal, with ONH defi-
cits occurring much later. The disparity between these
studies may relate to the models used. In the micro-bead
model used by Crish et al., the IOP elevations were max-
imally 10 mmHg and maintained for long periods, whilst
the laser model used here and by others produces typical
IOP rises of 25 mmHg for shorter periods. It is possible
that modest, prolonged increases in IOP gradually com-
promise axonal transport efficiency, which is first manifest
at the distal synapses, whilst greater increases in IOP
physically constrict axons at the ONH.
We found axonal cytoskeletal abnormalities, including
neurofilament beading and swellings, in the ONH at 24 h
after induction of raised IOP. This suggests that axonal
transport disruption is mechanical, and not simply func-
tional, in a subset of axons at very early time points.
Nevertheless, in other axons, it is likely that active axonal
transport dysfunction significantly preceded physical
damage, an argument supported by the results of Salinas-
Navarro et al. [42], who counted fewer RGCs in retinas
back-labelled by a tracer that undergoes active transport
than in retinas back-labelled by a passively diffusing tracer.
In contrast to the ONH, no axonal cytoskeletal abnormal-
ities were present in the entire myelinated ON and OT until
3 days, with progressively greater damage at 7 and
14 days. The results support the findings of others that IOP
elevations of the magnitude recorded in this study elicit an
early insult at the lamina of the ONH with Wallerian-like
degeneration of axons distal to the site of injury [16, 20,
38]. Regarding axonal cytoskeletal degeneration, a previ-
ous study in monkeys showed accumulation of npNFH in
the ON following raised IOP [22]. Using immunohisto-
chemistry, we found a similar, robust increase in npNFH
labelling in degenerating axons; however, Western blotting
of ON samples revealed no increase in the npNFH 200-kDa
Fig. 9 Temporal characterisation of downregulation of the RGC-
specific mRNAs Thy1 and NFL in the retina following induction of
experimental glaucoma (a, n = 4–9) and NMDA-induced excitotox-
icity (b, n = 6–7), as determined by quantitative real-time RT–PCR.
*P \ 0.05, ***P \ 0.001 by one-way ANOVA followed by post hoc
Tukey’s test. c–e Evaluation of axonal degeneration and axonal
transport disruption in the ONH after NMDA-induced excitotoxicity.
At 1 day after NMDA treatment, SMI-32 (npNFH) immunostaining
throughout the ONH and ON appears normal (c). By 2 days,
numerous axonal swellings and abnormalities are visible throughout
the white matter tract (d). No accumulation of APP is evident at the
ONH following administration of NMDA, as shown in this rat killed
at 2 days (e). Scale bar c, d 25 lm, e 100 lm
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band, rather the appearance of a continuum of low-
molecular weight bands. These bands almost certainly
represent breakdown products and may account for the
increased immunoreactivity in tissue sections. npNFH is
more labile and sixfold more susceptible than pNFH to
degradation by calpain [34] and our data indicate that it
degenerates more rapidly than pNFH.
The strikingly early nature of pathological changes at
the ONH prompted the question as to whether RGC somas
are irreversibly injured at this same time. Our data indicate
not. Down-regulation of RGC-specific mRNAs, which are
sensitive early indicators of RGC viability [10, 16, 43],
occurred subsequent to axonal changes at the ONH and
markedly later than in retinas subjected to NMDA-induced
somatic excitotoxicity. It can be argued that the elevated
IOP placed a considerable physiological stress on a pro-
portion of RGC somas as evidenced by their upregulation
of the molecular chaperone Hsp27; yet, this response also
occurred in rats with normal IOPs that underwent ON crush
and may simply have been caused by damage to the axonal
compartment.
The long-term objective of glaucomatous pharmaco-
therapy is not merely neuroprotection of surviving RGCs,
but regeneration of injured/disconnected axons. Within the
CNS, endogenous regenerative attempts are always
unsuccessful. In the visual system, RGC axons display only
transient, local sprouting, proximal to the lesion site after
ON crush [3], and interestingly, even this limited response
occurs only when the injury is within 3 mm of the eye, not
if it is administered to the distal ON [13]. Unlike the cat-
astrophic injury caused by traumatic axonopathies, such as
ON crush, RGCs are lost gradually during chronic ocular
hypertension and only a proportion of the population will
die. It follows that the inhibitory environment for regen-
eration may be less pronounced and regeneration strategies
more effective. Surprisingly, no data are available on the
endogenous regenerative response of RGCs during exper-
imental glaucoma. Delineating such information is of
utmost importance. We have shown in the current study
that RGC axonal injury is first evident at the ONH and that
the somas remain viable for a number of days; thus, we
hypothesised that endogenous RGC regeneration should
proceed at least to the ONH. To examine putative axonal
regeneration, we employed Gap43, the quintessential
marker of axon growth, but one which can be expressed in
non-regenerative situations [25], hence the caveat ‘‘puta-
tive’’. Upregulation of Gap43 protein in the retina was first
detectable by 3d after IOP elevation. By 14 days, numer-
ous Gap43-positive axons were observed in the pre-laminar
ONH, some extending to the transition region of the ONH.
For comparative purposes, we analysed Gap43 in rats
subjected to NMDA-induced excitotoxicity and ON crush.
After NMDA treatment, no Gap43 expression was
detected, a result consistent with early RGC somal death.
After ON crush, substantial Gap43 immunoreactivity was
observed, which extended to the crush site. The overall
results provide further evidence that the ONH is the prin-
cipal site of axonal injury in this rat glaucoma model and
that chronically raised IOP induces a crush-like insult at
this location.
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